ATE22439T1 - 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine. - Google Patents

2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.

Info

Publication number
ATE22439T1
ATE22439T1 AT82102908T AT82102908T ATE22439T1 AT E22439 T1 ATE22439 T1 AT E22439T1 AT 82102908 T AT82102908 T AT 82102908T AT 82102908 T AT82102908 T AT 82102908T AT E22439 T1 ATE22439 T1 AT E22439T1
Authority
AT
Austria
Prior art keywords
alkyl
phenyl
substituted
substituted phenyl
amino
Prior art date
Application number
AT82102908T
Other languages
German (de)
English (en)
Inventor
Hermann Breuer
William A Slusarchiyk
Theodor Denzel
Uwe D Treuner
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of ATE22439T1 publication Critical patent/ATE22439T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT82102908T 1981-04-09 1982-04-05 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine. ATE22439T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25267281A 1981-04-09 1981-04-09
EP82102908A EP0062876B1 (en) 1981-04-09 1982-04-05 2-oxo-1-(((substituted sulfonyl)amino)carbonyl)azetidines

Publications (1)

Publication Number Publication Date
ATE22439T1 true ATE22439T1 (de) 1986-10-15

Family

ID=22957021

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82102908T ATE22439T1 (de) 1981-04-09 1982-04-05 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.

Country Status (16)

Country Link
EP (1) EP0062876B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS57179156A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE22439T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU561650B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1246572A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3273405D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK162582A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES8307741A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR76486B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU187568B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE52938B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL65407A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ199981A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH23122A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT74730B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA821768B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272726C (en) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4548747A (en) * 1983-05-02 1985-10-22 E. R. Squibb & Sons, Inc. 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4587051A (en) * 1983-07-18 1986-05-06 E. R. Squibb & Sons, Inc. Desulfonation process for preparing 2-azetidinones
US4584132A (en) * 1983-08-09 1986-04-22 Hoffmann-La Roche Inc. 1-(N-phosphinylcarbamoyl) β-lactam antibacterial agents
US4559335A (en) * 1983-10-03 1985-12-17 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
US4831130A (en) * 1984-05-31 1989-05-16 Hoffmann-La Roche Inc. β-lactam antibacterial agents
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
US4743685A (en) * 1985-09-26 1988-05-10 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
EP0308416A1 (en) * 1986-05-23 1989-03-29 The Upjohn Company N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
FI20031113A7 (fi) * 2003-07-29 2005-01-30 Outokumpu Oy Menetelmä ja laitteisto leijupetiuunin arinalta poistettavan materiaalin jäähdyttämiseksi
EP2308562B1 (en) * 2003-12-25 2015-02-25 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
EP2484680B1 (en) * 2005-12-07 2013-06-26 Basilea Pharmaceutica AG Useful Combinations of Monobactam Antibiotics with beta-Lac-tamase Inhibitors
KR20110086742A (ko) 2008-12-19 2011-07-29 화이자 인코포레이티드 모노카밤
US20220169610A1 (en) 2020-11-30 2022-06-02 Sophrosyne Pharmaceuticals Limited Compounds and methods for treating alcohol disorder
WO2022261441A2 (en) 2021-06-10 2022-12-15 Sophrosyne Pharmaceuticals Limited Crystalline forms of aldh2 modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2559307C2 (de) * 1975-12-31 1984-05-24 Rheinhold & Mahla Gmbh, 6800 Mannheim Verfahren und Vorrichtung zum Verkleben zweier Materialbahnen
US4195021A (en) * 1977-10-26 1980-03-25 Eli Lilly And Company 1,3-Disubstituted 2-azetidinone antibitotics
CA1338538C (en) * 1979-06-08 1996-08-20 Taisuke Matsuo 1-sulfo-2-oxoazetidine derivatives and their production

Also Published As

Publication number Publication date
PT74730A (en) 1982-05-01
ES8405369A1 (es) 1984-06-01
EP0062876A1 (en) 1982-10-20
ES511238A0 (es) 1983-07-01
PH23122A (en) 1989-05-05
HU187568B (en) 1986-01-28
ES8405368A1 (es) 1984-06-01
CA1246572A (en) 1988-12-13
IE52938B1 (en) 1988-04-13
NZ199981A (en) 1985-08-16
ES521479A0 (es) 1984-06-01
ES521480A0 (es) 1984-06-01
ES8307741A1 (es) 1983-07-01
AU561650B2 (en) 1987-05-14
GR76486B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-08-10
IL65407A0 (en) 1982-07-30
ZA821768B (en) 1983-01-26
JPH0372616B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-11-19
PT74730B (en) 1983-10-25
AU8155782A (en) 1982-10-14
IE820781L (en) 1982-10-09
DK162582A (da) 1982-10-10
EP0062876B1 (en) 1986-09-24
DE3273405D1 (en) 1986-10-30
JPS57179156A (en) 1982-11-04

Similar Documents

Publication Publication Date Title
ATE22439T1 (de) 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
ATE64393T1 (de) Monosulfactame.
DE3781337D1 (de) 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine.
DE3566664D1 (de) Substituted pyrazolin-5-one
DE3783159D1 (de) 2-oxo-1-(substituierte phosphorigsaeure)azetidine.
GR75173B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX9302388A (es) Oxazolidinonas fungicidas y composicion fungicida que las contiene
ATE46516T1 (de) Phosphonamidthioate-insektizide.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties